[The role of PCSK9-inhibitors and of lipoprotein apheresis in the treatment of homozygous and severe heterozygous familial hypercholesterolemia: A rivalry, or are things quite different?]

Bláha, Vladimír

[The role of PCSK9-inhibitors and of lipoprotein apheresis in the treatment of homozygous and severe heterozygous familial hypercholesterolemia: A rivalry, or are things quite different?] [electronic resource] - Vnitrni lekarstvi - 43-50 p. digital

Publication Type: Journal Article

0042-773X


Antibodies, Monoclonal
Anticholesteremic Agents--therapeutic use
Blood Component Removal
Cholesterol, LDL
Humans
Hypercholesterolemia
Hyperlipoproteinemia Type II--drug therapy
Lipoproteins
PCSK9 Inhibitors
Proprotein Convertase 9